Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nestle Sa ADR (OP:NSRGY)

98.09 -2.00 (-1.99%)
Streaming Delayed Price Updated: 2:26 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nestle Sa ADR

< Previous 1 2 3 4 5 6 Next >
Sip on Profits: 3 Top Coffee Stocks to Perk Up Your Returns
Check how investing in coffee stocks like Starbucks, Nestle, and J.M. Smucker can turn your daily coffee savings into long-term gains. 
Via InvestorPlace
10 Best Vanguard Funds to Buy Right Now
These 10 Vanguard stock ETFs can help you build a top-notch portfolio. 
Via The Motley Fool
Topics ETFs
Plunge Protection: 3 Stocks to Hold When the Market Dives
The bull market won't last forever. These are three defensive stocks to buy before the inevitable next market swoon. 
Via InvestorPlace
Move Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.
The search for the next GLP-1 drugs that will be blockbuster winners during the next market cycle is on, and here are three contenders. 
Via InvestorPlace
Nestlé To Develop Products For Users Of 'Miracle' Weight-Loss Drugs Like Ozempic, Wegovy
Via Benzinga
Fisker Stock Alert: Fisker Ends Roadside Assistance for Ocean Drivers
Fisker stock is in the news Wednesday as the electric vehicle (EV) maker continues to deal with problems amid recent financial struggles. 
Via InvestorPlace
Topics Electric Vehicles
Nestle Enters the Weight Loss Game With Food for Ozempic Users. What to Know.
Nestle is getting into the weight loss business with new packs of frozen food designed for Ozempic users and others trying to slim down. 
Via InvestorPlace
Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You
Nestlé SA launches Vital Pursuit, a new food line tailored for GLP-1 weight loss medication users, featuring protein, fiber, and essential nutrients. Available Q4 nationwide. 
Via Benzinga
Fresh on the Market: 3 Newly Listed Stocks Poised to Skyrocket
Expected to soar, these newly listed stocks to buy represent companies with solid fundamentals and a stellar growth outlook. 
Via InvestorPlace
Furry Tech Boom: 3 Pet Stocks Unleashing the Power of AI
Despite the post-pandemic slowdown, the pet care industry remains healthy, as these three AI pet stocks to buy now demonstrate. 
Via InvestorPlace
Topics Artificial Intelligence
IBTA Stock IPO: When Does Ibotta Go Public? What Is the Ibotta IPO Price Range?
Although the upcoming Ibotta IPO brings excitement to the new-listing space, IBTA stock faces a tricky environment. 
Via InvestorPlace
Topics Initial Public Offering
Trash Bin Alert: 3 Cocoa Stocks to Dump Before the Bitter End
Cocoa prices are still pushing aggressively higher, and may still have room to run. It's why we’re looking at top cocoa stocks to sell. 
Via InvestorPlace
Branding Behemoths: 3 Consumer Staples Stocks With Super Strong Moats
Investors looking for consumer staples stocks with moats should consider these three super strong investments. 
Via InvestorPlace
Top Wall Street Analysts Flag US Market Concentration Anxiety, Advise Investors To Adopt 'Barbell Approach'
Goldman Sachs urges investors to diversify geographically due to high concentration in US tech stocks, with Japan, healthcare, and European GRANOLAS highlighted as promising markets. 
Via Benzinga
Boiling Water Reduces Microplastics: What Does It Mean For Coca-Cola, PepsiCo's Bottled Water Brands?
Microplastics are small plastic fragments found everywhere and can cause harm to human health. Boiling and filtering tap water can reduce them by 90%. 
Via Benzinga
The Steady Eddies: 3 Dividend Stocks for a Decade of Dependable Growth
If you're looking for a steady list of dividend stocks to depend on for the next decade, these are the clear names. 
Via InvestorPlace
11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
A group of stocks, which Goldman Sachs dubbed the "Granolas," accounted for 50% of gains of the Stoxx Europe 600 Index for the past year. 
Via Benzinga
Freshpet Stock: Leading the Pack with Solid Earnings Results
Freshpet, a leader in the refrigerated pet food space, has seen its stock soar recently due to impressive financial results. 
Via MarketBeat
Topics Earnings
Move Over Magnificent 7, Say Hello to the GRANOLAS
Dive into the compelling world of GRANOLAS stocks: Europe's elite players shaping the future of pharmaceuticals, tech, and consumer goods. 
Via InvestorPlace
Top 3 Struggling Stocks to Avoid as Cocoa Prices Soar
Investors want to keep in mind these stocks to avoid amid higher cocoa prices. Some analysts don’t expect improvement any time soon. 
Via InvestorPlace
22 Blue-Chip European Dividend Growth Stocks
A discussion of insights on European dividend growth stocks. 
Via Talk Markets
Should The Day After The Super Bowl Be A Holiday? Here's What Benzinga Readers Said And What History Shows
The day following the Super Bowl often witnesses decreased productivity and a significant uptick in employee absences. 
Via Benzinga
Game Day Gainers: 3 Food & Beverage Stocks Primed for a Super Bowl Boost
With the big game coming up, Super Bowl stocks become a thing for sports-loving investors looking to profit. 
Via InvestorPlace
3 Purrfect Stocks to Buy for the Booming Pet Care Industry
Despite the post-pandemic slowdown, stocks within the pet care industry are good long-term investments because the revenue trend is higher. 
Via InvestorPlace
Codexis Clinches Deal With Nestlé Health Science, Eyes Up To $45M Milestone In EPI Treatment Breakthrough
Codexis, Inc. (NASDAQ: CDXS) entered a purchase deal with Nestlé S.A.(OTC: NSRGY) Nestlé Health Science for CDX-7108, a potential treatment for exocrine pancreatic insufficiency (EPI).  
Via Benzinga
Weight Loss Drugs By Novo Nordisk, Eli Lilly Don't Deter Nestle's Coffee Demand - CEO Explains Why
Nestle S.A. (OTC: NSRGY) CEO Mark Schneider stated that despite the rising use of weight loss medications like Eli Lilly And Company's (NYSE: LLY) Zepbound and Novo Nordisk's  
Via Benzinga
25% of Warren Buffett's Secret Portfolio Is Invested in These 3 ETFs. Here's Why They're Great Picks for 2024.
Buffett didn't personally pick these ETFs. But all three could make him money in the new year. 
Via The Motley Fool
Topics ETFs
Diversifying Your Portfolio With Plant-Based Options
Investors see profit potential in the plant-based market due to rising consumer demand, ESG focus, and the growth of vegan products in various industries, including pharmaceuticals. However, market... 
Via Talk Markets
3 Mutual Funds to Invest in for Pro Management and Low Fees
People wanting to invest for the future without actively managing their own money should consider one of these top mutual funds. 
Via InvestorPlace
Are People Done Buying Chips And Soda? Stock Market Winners And Losers From Rise Of Ozempic, Weight-Loss Drugs
With health and wellness becoming increasingly popular in the United States, it’s no surprise that weight-loss drugs like Ozempic and Wegovy have gone viral on TikTok and other social platf 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.